Search

everythinglearnresearchcommunity

for

Search:↓

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Six genetic conditions are often linked to complete scalp hair loss in children.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Early diagnosis and genetic evaluation of ADULT syndrome are crucial to reduce stress and medical costs.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Dissecting cellulitis of the scalp is a condition that causes inflammation and scarring on the scalp, mainly affecting African-American men, and can lead to permanent hair loss.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Plica neuropathica is a tangled hair condition that may be caused by hair damage or psychiatric issues and is treated by cutting the hair and addressing mental health.

Hoxc13 gene affects wool length in Gansu alpine fine-wool sheep.

sPLA2-IIE is crucial for normal hair follicle structure and skin health.

Excessive selenium in supplements can cause hair loss and nail issues.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Pili torti hair twists due to uneven outer root sheath cell development.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.